A recent study reveals that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who stop conventional lifestyle plans.
Published data in a leading medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals using these drugs need to be informed of the potential of quick rebound weight gain when the treatment concludes," stated lead investigator Dr. Susan Jebb.
Such speed of regain means a reversion to original mass in about one and a half years.
Comparing Approaches
The analysis, which examined 37 of trials involving over 9,000 of participants, compared the outcomes of these new drugs with other pills.
The team emphasize that individuals who shed pounds through dieting typically experience a slower weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Fast Regain
Nutrition scientists suggest the mechanism of the injections accounts for the heightened rebound.
These medications copy a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 levels far above than normal may cause the system to produce less of its endogenous GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making excessive eating much more probable."
A Lifelong Issue?
Health authorities suggest the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.
A number of clinicians say that, considering the likelihood of relapse, the therapy is often ongoing.
This perspective is echoed by pharmaceutical companies, who state that the results "highlight the persistent nature of obesity," akin to managing diseases like high blood pressure.
Patient Accounts
Users who have come off the jabs explain a powerful return of hunger.
"I experienced a trigger that goes on and you're instantly ravenous," said one woman.
The struggle is compounded if individuals have not developed permanent lifestyle or habit modifications during treatment.
Widespread Use
Survey data show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Use is more common among women compared to men.
- The middle-aged age group shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, experts caution that while the jabs are potent tools for shedding pounds, they are not a magic fix and long-term success likely depends on combined lifestyle support.
